世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

無細胞DNA(cfDNA)採血管の世界市場成長 2023-2029


Global Cell-Free DNA(cfDNA) Blood Collection Tube Market Growth 2023-2029

LPI(LPインフォメーション)の最新調査によると、世界の無細胞DNA(cfDNA)採血管市場規模は2022年に100万米ドルと評価されました。下流市場での需要の増加に伴い、無細胞DNA(cfDNA)採血管は、レビュー期間中のC... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年10月30日 US$3,660
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
104 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、世界の無細胞DNA(cfDNA)採血管市場規模は2022年に100万米ドルと評価されました。下流市場での需要の増加に伴い、無細胞DNA(cfDNA)採血管は、レビュー期間中のCAGR %で2029年までに百万米ドルの再調整規模になると予測されています。
この調査レポートは、世界の無細胞DNA(cfDNA)採血管市場の成長の可能性を明らかにします。無細胞DNA(cfDNA)採血管は今後の市場でも安定した成長が期待される。しかし、無細胞DNA採血管の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、無細胞DNA採血管(cfDNA)市場がもたらす莫大な機会を活用するために、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供を行う必要がある。
遊離DNAは、循環DNAや無細胞DNAとも呼ばれ、血漿、血清、尿などの体液中に存在する細胞外DNAを指す。
当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間は年平均成長率5%で成長する。世界の医療支出は世界GDPの10%を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっている。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。同市場は、世界的な高度医療サービスに対する需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断と治療に対する意識の高まりなど、いくつかの要因によって牽引されている。
主な特徴
無細胞DNA(cfDNA)採血管市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、無細胞DNA(cfDNA)採血管市場の現在の規模と成長の概要を提供しています。過去データ、タイプ別市場区分(例:5ml、10ml)、地域別内訳などが含まれる場合があります。
市場促進要因と課題:レポートでは、政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、無細胞DNA(cfDNA)採血管市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、無細胞DNA(cfDNA)採血管市場における競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業やその市場に与える潜在的な影響にもスポットを当てています。
技術開発:この調査レポートは、無細胞DNA(cfDNA)採血管産業における最新の技術開発を掘り下げることができます。これには、無細胞DNA(cfDNA)採血管技術の進歩、無細胞DNA(cfDNA)採血管の新規参入企業、無細胞DNA(cfDNA)採血管の新規投資、無細胞DNA(cfDNA)採血管の将来を形作るその他の技術革新が含まれます。
川下企業の好み:この調査レポートは、無細胞DNA採血管市場における顧客の購買行動と採用動向を明らかにします。無細胞DNA(cfDNA)採血管製品に対する顧客の購買決定や嗜好に影響を与える要因も含まれています。
政府の政策とインセンティブこの調査レポートは、無細胞DNA(cfDNA)採血管市場に対する政府の政策とインセンティブの影響を分析しています。これには、無細胞DNA(cfDNA)採血管市場の促進を目的とした規制の枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性この調査レポートは、無細胞DNA(cfDNA)採血管市場の環境への影響と持続可能性の側面を評価しています。
市場予測と将来展望:調査レポートでは、実施した分析に基づいて、無細胞DNA(cfDNA)採血管産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、無細胞DNA(cfDNA)採血管市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
無細胞DNA(cfDNA)採血管市場は、タイプ別と用途別に分けられる。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
5ml
10ml
用途別セグメント
体外診断
科学研究
また、本レポートでは地域別に市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ロシュ
ノナカス
ストレック
Cwbio ITグループ
威海威高
バニーティース
ディアカルタ
ビーバー
アーデントバイオメッド
Hbxinle
サーモフィッシャーサイエンティフィック
本レポートで扱う主な質問
世界の無細胞DNA(cfDNA)採血管市場の10年見通しは?
世界および地域別に、無細胞DNA(cfDNA)採血管市場の成長を促進する要因は何か?
市場別、地域別で最も急成長する技術は何か?
無細胞DNA(cfDNA)採血管の市場機会は最終市場規模によってどのように異なるのか?
無細胞DNA(cfDNA)採血管のタイプ別、用途別内訳は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cell-Free DNA(cfDNA) Blood Collection Tube by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cell-Free DNA(cfDNA) Blood Collection Tube by Country/Region, 2018, 2022 & 2029
2.2 Cell-Free DNA(cfDNA) Blood Collection Tube Segment by Type
2.2.1 5ml
2.2.2 10ml
2.3 Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
2.3.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sales Market Share by Type (2018-2023)
2.3.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Price by Type (2018-2023)
2.4 Cell-Free DNA(cfDNA) Blood Collection Tube Segment by Application
2.4.1 In Vitro Diagnostics
2.4.2 Scientific Research
2.5 Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
2.5.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Market Share by Application (2018-2023)
2.5.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Price by Application (2018-2023)
3 Global Cell-Free DNA(cfDNA) Blood Collection Tube by Company
3.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Breakdown Data by Company
3.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales by Company (2018-2023)
3.1.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sales Market Share by Company (2018-2023)
3.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue by Company (2018-2023)
3.2.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Company (2018-2023)
3.2.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue Market Share by Company (2018-2023)
3.3 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Price by Company
3.4 Key Manufacturers Cell-Free DNA(cfDNA) Blood Collection Tube Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cell-Free DNA(cfDNA) Blood Collection Tube Product Location Distribution
3.4.2 Players Cell-Free DNA(cfDNA) Blood Collection Tube Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cell-Free DNA(cfDNA) Blood Collection Tube by Geographic Region
4.1 World Historic Cell-Free DNA(cfDNA) Blood Collection Tube Market Size by Geographic Region (2018-2023)
4.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cell-Free DNA(cfDNA) Blood Collection Tube Market Size by Country/Region (2018-2023)
4.2.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
4.4 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
4.5 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
4.6 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
5 Americas
5.1 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country
5.1.1 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country (2018-2023)
5.1.2 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Country (2018-2023)
5.2 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
5.3 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Region
6.1.1 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Region (2018-2023)
6.1.2 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Region (2018-2023)
6.2 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
6.3 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cell-Free DNA(cfDNA) Blood Collection Tube by Country
7.1.1 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country (2018-2023)
7.1.2 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Country (2018-2023)
7.2 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
7.3 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube by Country
8.1.1 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Country (2018-2023)
8.2 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
8.3 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell-Free DNA(cfDNA) Blood Collection Tube
10.3 Manufacturing Process Analysis of Cell-Free DNA(cfDNA) Blood Collection Tube
10.4 Industry Chain Structure of Cell-Free DNA(cfDNA) Blood Collection Tube
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cell-Free DNA(cfDNA) Blood Collection Tube Distributors
11.3 Cell-Free DNA(cfDNA) Blood Collection Tube Customer
12 World Forecast Review for Cell-Free DNA(cfDNA) Blood Collection Tube by Geographic Region
12.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Market Size Forecast by Region
12.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Forecast by Region (2024-2029)
12.1.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cell-Free DNA(cfDNA) Blood Collection Tube Forecast by Type
12.7 Global Cell-Free DNA(cfDNA) Blood Collection Tube Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.1.3 Roche Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Nonacus
13.2.1 Nonacus Company Information
13.2.2 Nonacus Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.2.3 Nonacus Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nonacus Main Business Overview
13.2.5 Nonacus Latest Developments
13.3 Streck
13.3.1 Streck Company Information
13.3.2 Streck Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.3.3 Streck Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Streck Main Business Overview
13.3.5 Streck Latest Developments
13.4 Cwbio IT Group
13.4.1 Cwbio IT Group Company Information
13.4.2 Cwbio IT Group Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.4.3 Cwbio IT Group Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cwbio IT Group Main Business Overview
13.4.5 Cwbio IT Group Latest Developments
13.5 Weihai Weigao
13.5.1 Weihai Weigao Company Information
13.5.2 Weihai Weigao Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.5.3 Weihai Weigao Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Weihai Weigao Main Business Overview
13.5.5 Weihai Weigao Latest Developments
13.6 Bunnyteeth
13.6.1 Bunnyteeth Company Information
13.6.2 Bunnyteeth Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.6.3 Bunnyteeth Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bunnyteeth Main Business Overview
13.6.5 Bunnyteeth Latest Developments
13.7 DiaCarta
13.7.1 DiaCarta Company Information
13.7.2 DiaCarta Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.7.3 DiaCarta Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 DiaCarta Main Business Overview
13.7.5 DiaCarta Latest Developments
13.8 BEAVER
13.8.1 BEAVER Company Information
13.8.2 BEAVER Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.8.3 BEAVER Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BEAVER Main Business Overview
13.8.5 BEAVER Latest Developments
13.9 Ardent Biomed
13.9.1 Ardent Biomed Company Information
13.9.2 Ardent Biomed Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.9.3 Ardent Biomed Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ardent Biomed Main Business Overview
13.9.5 Ardent Biomed Latest Developments
13.10 Hbxinle
13.10.1 Hbxinle Company Information
13.10.2 Hbxinle Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.10.3 Hbxinle Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hbxinle Main Business Overview
13.10.5 Hbxinle Latest Developments
13.11 Thermo Fisher Scientific
13.11.1 Thermo Fisher Scientific Company Information
13.11.2 Thermo Fisher Scientific Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.11.3 Thermo Fisher Scientific Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Thermo Fisher Scientific Main Business Overview
13.11.5 Thermo Fisher Scientific Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Cell-Free DNA(cfDNA) Blood Collection Tube market size was valued at US$ million in 2022. With growing demand in downstream market, the Cell-Free DNA(cfDNA) Blood Collection Tube is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cell-Free DNA(cfDNA) Blood Collection Tube market. Cell-Free DNA(cfDNA) Blood Collection Tube are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell-Free DNA(cfDNA) Blood Collection Tube. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell-Free DNA(cfDNA) Blood Collection Tube market.
Free DNA, also known as circulating DNA and cell-free DNA, refers to extracellular DNA present in body fluids such as plasma, serum or urine.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Cell-Free DNA(cfDNA) Blood Collection Tube market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cell-Free DNA(cfDNA) Blood Collection Tube market. It may include historical data, market segmentation by Type (e.g., 5ml, 10ml), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell-Free DNA(cfDNA) Blood Collection Tube market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell-Free DNA(cfDNA) Blood Collection Tube market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cell-Free DNA(cfDNA) Blood Collection Tube industry. This include advancements in Cell-Free DNA(cfDNA) Blood Collection Tube technology, Cell-Free DNA(cfDNA) Blood Collection Tube new entrants, Cell-Free DNA(cfDNA) Blood Collection Tube new investment, and other innovations that are shaping the future of Cell-Free DNA(cfDNA) Blood Collection Tube.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell-Free DNA(cfDNA) Blood Collection Tube market. It includes factors influencing customer ' purchasing decisions, preferences for Cell-Free DNA(cfDNA) Blood Collection Tube product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell-Free DNA(cfDNA) Blood Collection Tube market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell-Free DNA(cfDNA) Blood Collection Tube market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell-Free DNA(cfDNA) Blood Collection Tube market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell-Free DNA(cfDNA) Blood Collection Tube industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell-Free DNA(cfDNA) Blood Collection Tube market.
Market Segmentation:
Cell-Free DNA(cfDNA) Blood Collection Tube market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
5ml
10ml
Segmentation by application
In Vitro Diagnostics
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Nonacus
Streck
Cwbio IT Group
Weihai Weigao
Bunnyteeth
DiaCarta
BEAVER
Ardent Biomed
Hbxinle
Thermo Fisher Scientific
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cell-Free DNA(cfDNA) Blood Collection Tube market?
What factors are driving Cell-Free DNA(cfDNA) Blood Collection Tube market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cell-Free DNA(cfDNA) Blood Collection Tube market opportunities vary by end market size?
How does Cell-Free DNA(cfDNA) Blood Collection Tube break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Cell-Free DNA(cfDNA) Blood Collection Tube by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Cell-Free DNA(cfDNA) Blood Collection Tube by Country/Region, 2018, 2022 & 2029
2.2 Cell-Free DNA(cfDNA) Blood Collection Tube Segment by Type
2.2.1 5ml
2.2.2 10ml
2.3 Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
2.3.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sales Market Share by Type (2018-2023)
2.3.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue and Market Share by Type (2018-2023)
2.3.3 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Price by Type (2018-2023)
2.4 Cell-Free DNA(cfDNA) Blood Collection Tube Segment by Application
2.4.1 In Vitro Diagnostics
2.4.2 Scientific Research
2.5 Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
2.5.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Market Share by Application (2018-2023)
2.5.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue and Market Share by Application (2018-2023)
2.5.3 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Price by Application (2018-2023)
3 Global Cell-Free DNA(cfDNA) Blood Collection Tube by Company
3.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Breakdown Data by Company
3.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales by Company (2018-2023)
3.1.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sales Market Share by Company (2018-2023)
3.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue by Company (2018-2023)
3.2.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Company (2018-2023)
3.2.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Revenue Market Share by Company (2018-2023)
3.3 Global Cell-Free DNA(cfDNA) Blood Collection Tube Sale Price by Company
3.4 Key Manufacturers Cell-Free DNA(cfDNA) Blood Collection Tube Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cell-Free DNA(cfDNA) Blood Collection Tube Product Location Distribution
3.4.2 Players Cell-Free DNA(cfDNA) Blood Collection Tube Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cell-Free DNA(cfDNA) Blood Collection Tube by Geographic Region
4.1 World Historic Cell-Free DNA(cfDNA) Blood Collection Tube Market Size by Geographic Region (2018-2023)
4.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Cell-Free DNA(cfDNA) Blood Collection Tube Market Size by Country/Region (2018-2023)
4.2.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Sales by Country/Region (2018-2023)
4.2.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue by Country/Region (2018-2023)
4.3 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
4.4 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
4.5 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
4.6 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales Growth
5 Americas
5.1 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country
5.1.1 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country (2018-2023)
5.1.2 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Country (2018-2023)
5.2 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
5.3 Americas Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Region
6.1.1 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Region (2018-2023)
6.1.2 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Region (2018-2023)
6.2 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
6.3 APAC Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cell-Free DNA(cfDNA) Blood Collection Tube by Country
7.1.1 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country (2018-2023)
7.1.2 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Country (2018-2023)
7.2 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
7.3 Europe Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube by Country
8.1.1 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Country (2018-2023)
8.1.2 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Revenue by Country (2018-2023)
8.2 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Type
8.3 Middle East & Africa Cell-Free DNA(cfDNA) Blood Collection Tube Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell-Free DNA(cfDNA) Blood Collection Tube
10.3 Manufacturing Process Analysis of Cell-Free DNA(cfDNA) Blood Collection Tube
10.4 Industry Chain Structure of Cell-Free DNA(cfDNA) Blood Collection Tube
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cell-Free DNA(cfDNA) Blood Collection Tube Distributors
11.3 Cell-Free DNA(cfDNA) Blood Collection Tube Customer
12 World Forecast Review for Cell-Free DNA(cfDNA) Blood Collection Tube by Geographic Region
12.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Market Size Forecast by Region
12.1.1 Global Cell-Free DNA(cfDNA) Blood Collection Tube Forecast by Region (2024-2029)
12.1.2 Global Cell-Free DNA(cfDNA) Blood Collection Tube Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cell-Free DNA(cfDNA) Blood Collection Tube Forecast by Type
12.7 Global Cell-Free DNA(cfDNA) Blood Collection Tube Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.1.3 Roche Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Nonacus
13.2.1 Nonacus Company Information
13.2.2 Nonacus Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.2.3 Nonacus Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nonacus Main Business Overview
13.2.5 Nonacus Latest Developments
13.3 Streck
13.3.1 Streck Company Information
13.3.2 Streck Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.3.3 Streck Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Streck Main Business Overview
13.3.5 Streck Latest Developments
13.4 Cwbio IT Group
13.4.1 Cwbio IT Group Company Information
13.4.2 Cwbio IT Group Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.4.3 Cwbio IT Group Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cwbio IT Group Main Business Overview
13.4.5 Cwbio IT Group Latest Developments
13.5 Weihai Weigao
13.5.1 Weihai Weigao Company Information
13.5.2 Weihai Weigao Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.5.3 Weihai Weigao Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Weihai Weigao Main Business Overview
13.5.5 Weihai Weigao Latest Developments
13.6 Bunnyteeth
13.6.1 Bunnyteeth Company Information
13.6.2 Bunnyteeth Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.6.3 Bunnyteeth Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bunnyteeth Main Business Overview
13.6.5 Bunnyteeth Latest Developments
13.7 DiaCarta
13.7.1 DiaCarta Company Information
13.7.2 DiaCarta Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.7.3 DiaCarta Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 DiaCarta Main Business Overview
13.7.5 DiaCarta Latest Developments
13.8 BEAVER
13.8.1 BEAVER Company Information
13.8.2 BEAVER Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.8.3 BEAVER Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BEAVER Main Business Overview
13.8.5 BEAVER Latest Developments
13.9 Ardent Biomed
13.9.1 Ardent Biomed Company Information
13.9.2 Ardent Biomed Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.9.3 Ardent Biomed Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ardent Biomed Main Business Overview
13.9.5 Ardent Biomed Latest Developments
13.10 Hbxinle
13.10.1 Hbxinle Company Information
13.10.2 Hbxinle Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.10.3 Hbxinle Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hbxinle Main Business Overview
13.10.5 Hbxinle Latest Developments
13.11 Thermo Fisher Scientific
13.11.1 Thermo Fisher Scientific Company Information
13.11.2 Thermo Fisher Scientific Cell-Free DNA(cfDNA) Blood Collection Tube Product Portfolios and Specifications
13.11.3 Thermo Fisher Scientific Cell-Free DNA(cfDNA) Blood Collection Tube Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Thermo Fisher Scientific Main Business Overview
13.11.5 Thermo Fisher Scientific Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(その他)の最新刊レポート

本レポートと同じKEY WORD(blood)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/06/18 10:26

158.74 円

170.83 円

204.52 円

ページTOPに戻る